Expanding the biological application of fluorescent benzothiadiazole derivatives: a phenotypic screening strategy for anthelmintic drug discovery using caenorhabditis elegans

Cintra, Giovana Aparecida de Souza; Neto, Brenno A. D.; Carvalho, Pedro H. P. R.; Moraes, Carolina Borsoi; Freitas-Junior, Lucio Holanda Gondim.
SLAS Discov, v. 24, n. 7, p. 755-765, jun. 2019
Artículo en Inglés | SES-SP, SESSP-IBPROD, SES-SP | ID: bud-2787

Documentos relacionados

  1. Expanding the Biological Application of Fluorescent Benzothiadiazole Derivatives: A Phenotypic Screening Strategy for Anthelmintic Drug Discovery Using <i>Caenorhabditis elegans</i>.
  2. Expanding the biological application of fluorescent benzothiadiazole derivatives: a phenotypic screening strategy for anthelmintic drug discovery using caenorhabditis elegans
  3. Structure activity relationship and target prediction for ABX464 analogues in Caenorhabditis elegans.
  4. Bioassay-Guided Isolation of Anthelmintic Components from <i>Semen pharbitidis</i>, and the Mechanism of Action of Pharbitin.
  5. Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics.
  6. A phenotypic screen of the Global Health Priority Box identifies an insecticide with anthelmintic activity.
  7. Structure-Based Bioisosterism Design, Synthesis, Biological Evaluation and In Silico Studies of Benzamide Analogs as Potential Anthelmintics.
  8. Model nematodes as a practical innovation to promote high throughput screening of natural products for anthelmintics discovery in South Asia: Current challenges, proposed practical and conceptual solutions.
  9. Sensitivity of Haemonchus contortus to anthelmintics using different in vitro screening assays: a comparative study.
  10. Whole-organism phenotypic screening methods used in early-phase anthelmintic drug discovery.